Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ct Hospitalier Universitaire Toulouse — Human Necessities
Ct Hospitalier Universitaire Toulouse holds 75 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Ct Hospitalier Universitaire Toulouse |
| Technology | Human Necessities |
| Patents in slice | 75 |
| Recent patents in slice | 23 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Ct Hospitalier Universitaire Toulouse to Human Necessities.
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Recent filings
Latest patents from Ct Hospitalier Universitaire Toulouse in Human Necessities.
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Related pages
Navigate to parent entity pages.